Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “T Cell Malignancies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)UnknownNCT03093168
What this trial is testing

BCMA Chimeric Antigen Receptor Expressing T Cells in Multiple Myeloma

Who this might be right for
Multiple Myeloma
The Second Affiliated Hospital of Henan University of Traditional Chinese Medicine 10
Not applicableUnknownNCT04208074
What this trial is testing

Exercise Study for Breast Cancer Survivors

Who this might be right for
Breast Cancer
San Diego Biomedical Research Institute 30
Not applicableStudy completedNCT00296023
What this trial is testing

Donor Stem Cell Transplant in Treating Older or Frail Patients With Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+2 more
University of California, San Francisco 25
Very early researchLooking for participantsNCT04657861
What this trial is testing

APRIL CAR-T Cell Therapy for Patients With BCMA/TACI Positive Relapsed and/or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma in RelapseMultiple Myeloma, Refractory
Zhejiang University 36
Not applicableEnded earlyNCT04947618
What this trial is testing

Efficacy of Patient Management for Lymphoma Diagnosed at Nimes University Hospital From 1999 to 2018. DVR-Lym-Nim

Who this might be right for
Lymphoma, Malignant
Centre Hospitalier Universitaire de Nīmes 136
Testing effectiveness (Phase 2)Enrolling By InvitationNCT06027879
What this trial is testing

Anti-viral T-cell Therapy by Gamma Capture

Who this might be right for
AdenovirusCytomegalovirus InfectionsEpstein-Barr Virus Infections
Paul Szabolcs 25
Testing effectiveness (Phase 2)Ended earlyNCT00363779
What this trial is testing

Effect of Cyclosporine Therapy on Gene Expression in Patients With Large Granular Lymphocyte Leukemia

Who this might be right for
Large Granular Lymphocytic LeukemiaLGL Leukemia
National Cancer Institute (NCI) 5
Testing effectiveness (Phase 2)Study completedNCT04312841
What this trial is testing

Letermovir for the Prevention of Cytomegalovirus Reactivation in Patients With Hematological Malignancies Treated With Alemtuzumab

Who this might be right for
B-Cell Prolymphocytic LeukemiaChronic Lymphocytic LeukemiaPeripheral T-Cell Lymphoma+3 more
Ohio State University Comprehensive Cancer Center 6
Early research (Phase 1)WithdrawnNCT07428486
What this trial is testing

FLAG Chemotherapy In Combination With Lisaftoclax And Pelcitoclax In Patients With Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia

Who this might be right for
Phase IFLAG ChemotherapyLisaftoclax+3 more
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT02653976
What this trial is testing

SP-02L in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)

Who this might be right for
Peripheral T-Cell Lymphoma
Solasia Pharma K.K. 67
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07180927
What this trial is testing

DLL3 CAR-T Therapy Targeting Brain Tumors

Who this might be right for
Glioblastoma of Cerebellum
Shenzhen Geno-Immune Medical Institute 30
Early research (Phase 1)Looking for participantsNCT07443020
What this trial is testing

Fast TILs to Treat Metastatic Pleural Effusions From Epithelial or Mesothelial Primary Tumors

Who this might be right for
Malignant Pleural EffusionMalignant MesotheliomaPleural Effusion, Malignant+1 more
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) 10
Testing effectiveness (Phase 2)Looking for participantsNCT06855823
What this trial is testing

A Phase I/II Study of Golidocitinib Combined with Pomalidomide in R/R PTCL

Who this might be right for
Relapsed/Refractory Peripheral T-Cell Lymphoma (R/R PTCL)
Sun Yat-sen University 33
Early research (Phase 1)Ended earlyNCT03139370
What this trial is testing

Safety and Efficacy of MAGE-A3/A6 T Cell Receptor Engineered T Cells (KITE-718) in HLA-DPB1*04:01 Positive Adults With Advanced Cancers

Who this might be right for
Solid Tumor
Kite, A Gilead Company 16
Early research (Phase 1)Study completedNCT04322292
What this trial is testing

BCMA-directed CAR-T Cells Treatment in Subjects With r/r Multiple Myeloma

Who this might be right for
Multiple Myeloma
Institute of Hematology & Blood Diseases Hospital, China 9
Early research (Phase 1)Temporarily pausedNCT07388563
What this trial is testing

Azacitidine and Abatacept in Relapsed or Refractory T-Cell Lymphoma

Who this might be right for
Lymphoma, T Cell, PeripheralT-cell LymphomaAngioimmunoblastic T-cell Lymphoma+3 more
National Cancer Institute (NCI) 20
Testing effectiveness (Phase 2)Study completedNCT00047021
What this trial is testing

Combination Chemotherapy in Treating Patients With Recurrent or Refractory Leukemia or Lymphoma

Who this might be right for
LeukemiaLymphoma
Case Comprehensive Cancer Center 3
Not applicableStudy completedNCT04509804
What this trial is testing

Target Gene Sequencing for Advanced Stage, Relapsed or Refractory Natural Killer/T-cell Lymphoma

Who this might be right for
Lymphoid Neoplasm
Chinese Academy of Medical Sciences 26
Early research (Phase 1)Ended earlyNCT05038644
What this trial is testing

XmAb18968 (CD3-CD38) in Relapsed or Refractory Acute Leukemia and T Cell Lymphoblastic Leukemia

Who this might be right for
Acute Myeloid LeukemiaT Cell Acute Lymphoblastic LeukemiaT Cell Lymphoblastic Lymphoma
Ehab L Atallah 22
Testing effectiveness (Phase 2)Ended earlyNCT01729884
What this trial is testing

Vaccine Therapy in Treating Patients With Stage IV Hormone Receptor Positive Breast Cancer

Who this might be right for
HER2-positive Breast CancerMale Breast CancerRecurrent Breast Cancer+1 more
University of Washington 3
Next Page